Protecting Ovarian Function During Stem Cell Transplant
Treatments studied
Part of Blood & lymphatic, Women’s health & pregnancy clinical trials.
This study tests whether a medication called goserelin can help preserve fertility and menstrual cycles in women undergoing stem cell transplantation for blood cancers. The goal is to see if this drug can prevent or reduce damage to the ovaries from the transplant procedure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a blood cancer or blood disorder requiring autologous stem cell transplant (using your own stem cells)
- You are female, aged 14–50, with regular menstrual periods before transplant
- You have healthy heart, liver, and kidney function
- You have not previously gone through menopause
- You expect to live at least one year after transplant so your recovery can be monitored
- You are willing to sign a consent form and follow all study procedures
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a hormone injection called goserelin can help preserve fertility and menstrual function in young women receiving a stem cell transplant for blood cancer. The transplant itself can damage ovaries, so researchers want to see if this medication protects them.
This study tests whether a medication called goserelin can help protect a woman's fertility and menstrual cycles during a stem cell transplant treatment for aplastic anemia (a blood disorder). The goal is to see if the medication prevents permanent damage to the ovaries from the transplant procedure.
This study tests a regenerative stem cell therapy to improve fertility in men with testicular failure or low sperm count and women with early ovarian failure. It is for people who have already tried standard treatments without success.
This trial tests two hormone-blocking injections (leuprolide and goserelin) to suppress ovarian function in premenopausal women with breast cancer. It aims to see how well these drugs work when taken with standard hormone pills.
This trial is testing whether giving the drug goserelin in a different spot on the body works just as well for suppressing ovarian function in premenopausal women with hormone receptor positive breast cancer. You may be a fit if you've already been on goserelin shots in your abdomen for at least 6 months.
This study looks at how a treatment called StemCell Regenera, which uses a growth factor medicine (Filgrastim), affects the blood of women with poor ovarian response or low egg reserve. The goal is to understand how the treatment might help reactivate the ovaries.
Hear when a new Ovarian Insufficiency trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.